Rex Healthcare Selects Global Med's SafeTrace(R) Application to Manage its Blood Services Program DENVER, Dec. 17 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a division of Global Med Technologies(R), Inc. (BULLETIN BOARD: GLOB) ("Global Med" or the "Company"), announced the signing of an agreement for its SafeTrace(R) donor management system with Rex Healthcare located in Raleigh, North Carolina. Terms of the agreement were not disclosed. "We chose SafeTrace because of its built-in safety features, which will help us provide high quality services to our donors, which in turn enhances the quality of blood products for our patients," said Dr. Timothy Carter, Laboratory Director at Rex Healthcare. Dr. Carter added, "Additionally, SafeTrace provides donor recruitment tools that we plan to use for expansion of our donor base and improved donor retention." Thomas F. Marcinek, President and COO of Global Med Technologies, Inc., said, "We are very pleased that Rex Healthcare selected SafeTrace to manage its blood services program." Mr. Marcinek added, "Rex Healthcare joins our growing list of prestigious clients using our products to help them provide the highest standard of care and services to blood donors and patients." About Rex Healthcare Rex Healthcare is a private, not-for-profit health care system that has provided superior care to Wake County and the surrounding area since 1894. The Rex hospital campus is the heart of the Rex Healthcare network, including a 394-bed acute care hospital, family birth center, cancer center, convalescent care center, same day surgery center, heart & vascular center and wellness center. For more information about Rex Healthcare, visit its website at http://www.rexhealth.com/ . About Global Med Technologies, Inc. Global Med Technologies, Inc. is an e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. blood centers and transfusion services. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Together, SafeTrace Tx(R)* and SafeTrace provide Vein-to- Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, call 800-WYNDGATE or visit http://www.globalmedtech.com/ , http://www.peoplemed.com/ and http://www.wyndgate.com/ . This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. *Patent Pending DATASOURCE: Global Med Technologies, Inc. CONTACT: Press Inquiries, Patti Larson, Senior Director of Marketing Development, +1-916-404-8492, , or Investor Inquiries, Tom Marcinek, President and COO, +1-916-404-8413, , both of Wyndgate Technologies, for Global Med Technologies, Inc. Web site: http://www.peoplemed.com/ Web site: http://www.rexhealth.com/ Web site: http://www.globalmedtech.com/

Copyright